|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
1,250,000,000 |
Market
Cap: |
130.68(B) |
Last
Volume: |
8,066,759 |
Avg
Vol: |
8,489,398 |
52
Week Range: |
$63.15 - $117.41 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 425 |
Guru Rank Value : 4.8 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
305,285 |
766,519 |
836,125 |
874,583 |
Total Sell Value |
$30,817,227 |
$73,404,787 |
$79,113,020 |
$82,165,066 |
Total People Sold |
1 |
4 |
4 |
4 |
Total Sell Transactions |
6 |
13 |
19 |
28 |
End Date |
2025-01-19 |
2024-10-18 |
2024-04-19 |
2023-04-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dickinson Andrew D |
Chief Financial Officer |
|
2025-04-15 |
4 |
AS |
$106.40 |
$266,000 |
D/D |
(2,500) |
168,174 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-03-17 |
4 |
AS |
$110.53 |
$276,325 |
D/D |
(2,500) |
170,674 |
|
-8% |
|
Wilfong Diane E |
Interim Corp Controller & CAOO |
|
2025-03-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,096 |
|
-8% |
|
Patterson Sandra |
SVP, Controllership |
|
2025-03-10 |
4 |
D |
$117.21 |
$73,139 |
D/D |
(624) |
39,453 |
|
- |
|
Patterson Sandra |
SVP, Controllership |
|
2025-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,952 |
40,077 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-03-10 |
4 |
D |
$117.21 |
$451,845 |
D/D |
(3,855) |
173,174 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-03-10 |
4 |
OE |
$0.00 |
$1,145,842 |
D/D |
25,897 |
177,029 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-03-10 |
4 |
AS |
$117.30 |
$2,118,696 |
D/D |
(17,929) |
169,061 |
|
-12% |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-03-10 |
4 |
D |
$117.21 |
$1,363,387 |
D/D |
(11,632) |
630,268 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,024 |
641,900 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-03-10 |
4 |
D |
$117.21 |
$132,447 |
D/D |
(1,130) |
36,562 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,343 |
37,692 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-03-10 |
4 |
D |
$117.21 |
$457,939 |
D/D |
(3,907) |
124,152 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,080 |
128,059 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-02-18 |
4 |
AS |
$104.09 |
$260,225 |
D/D |
(2,500) |
169,061 |
|
-2% |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-02-12 |
4 |
AS |
$102.22 |
$14,073,241 |
D/D |
(137,676) |
171,223 |
|
0% |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-02-12 |
4 |
OE |
$57.92 |
$9,260,873 |
D/D |
137,676 |
308,899 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
12,371 |
34,011 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-02-04 |
4 |
D |
$97.99 |
$4,227,093 |
D/D |
(43,138) |
171,223 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
84,488 |
214,361 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-02-04 |
4 |
D |
$97.99 |
$10,598,206 |
D/D |
(108,156) |
617,876 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
224,504 |
726,032 |
|
- |
|
Patterson Sandra |
SVP, Controllership |
|
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
709 |
37,787 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-02-04 |
4 |
D |
$97.99 |
$4,474,811 |
D/D |
(45,666) |
119,979 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
90,505 |
165,645 |
|
- |
|
992 Records found
|
|
Page 1 of 40 |
|
|